Emerging Financing Alternatives for Life Sciences Companies: Opportunities and Pitfalls You Need to Know
The emergence of real-world data and new digital technologies is fueling growth in the life sciences sector. This trend is resulting to increased investor interest and record funding. In this regard, life sciences businesses are now turning to alternative financing options to fund their growth. These include royalty financing, initial public offerings (IPOs), and collaborative arrangements.
However, companies that enter these types of financing must be wary of potential drawbacks and reporting challenges. They must clearly understand and comply with the updated rules related to these alternatives. Counsel to businesses must develop an advanced strategic approach to leverage potentials and avoid legal issues.
Join a panel of key thought leaders and practitioners assembled by The Knowledge Group as they provide the audience with an in-depth discussion of these financing alternatives for the life sciences industry. Speakers will dig deeper as they analyze critical issues surrounding this topic. They will also offer practical tips and strategies to maximize its potentials in light of the recent regulatory developments.
This LIVE Webcast will discuss the following:
- Life Sciences Funding: Trends and Statistics
- Financing Alternatives
- Navigating Potentials
- Red Flags
- Risk Mitigation Strategies
- What Lies Ahead
Laurie A. Burlingame, Partner
Goodwin Procter LLP
II. Various Alternatives for Raising Capital
- Traditional Equity
- Government Grants
- Licensing, Partnerships or Collaborations
- Royalty transactions
- Reg CF (“Crowdfunding”)
- Initial Public Offering
- Form 10
- Reverse Merger
- Reg A+ III
III. Preparing for financing
- Corporate topics to consider for due diligence
Sara H. Shanti, Partner
Benesch Friedlander Coplan & Aronoff LLP
Regulatory Compliance Considerations
- Multi-Layered Governance
- Compliance 101
- Firm and Executive Liability
- Data Security and Public Perception
- Reimbursement and Future Valuation
Who Should Attend:
- Finance Lawyers and Advisers
- Finance Executives
- Accounting Executives
- Finance Reporting Officers
- Investment Advisers
- Biotech, Pharma and Other Life Science Companies
Laurie Burlingame is a partner in the firm’s nationally recognized Life Sciences Practice Group. She represents private and public companies across the spectrum of the life sciences industry, including pharmaceuticals, medical devices, diagnostics and biological materials. Ms. Burlingame also represents leading venture capital firms focused on the life sciences industry in connection with their portfolio company investments.
Ms. Burlingame often serves as outside general counsel to her clients, closely advising management teams and boards of directors on a wide variety of matters throughout the company’s life cycle, including formation and founder issues, venture capital financings, public offerings, mergers and acquisitions, licensing transactions, strategic collaborations, commercial transactions, corporate governance and other general corporate matters.
Laurie Burlingame is a partner in the firm’s nationally recognized Life Sciences Practice Group. She represents private and public companies …
Sara Shanti is a partner in Benesch’s Health Care & Life Sciences Practice Group. Sara represents health care providers and technology companies in matters related to data privacy and security, health care regulatory compliance, and mergers and acquisitions.
Sara’s practice focuses on counseling clients on various digital health matters, including artificial intelligence, breach notification, mobile applications, and telemedicine. Sara’s experience includes advising clients on transferring data across multi-national borders, implementing compliance programs, launching health apps, and responding to federal investigations and security incidents, including ransomeware attacks. Her experience extends to consumer and minor patient rights, medical staff relationships, and transactional matters.
Sara Shanti is a partner in Benesch’s Health Care & Life Sciences Practice Group. Sara represents health care providers and …
Print and review course materials
Method Of Presentation:
General knowledge of corporate finance
NY Category of CLE Credit:
Areas of Professional Practice
Unlock All The Knowledge and Credit You Need
Leading Provider of Online Continuing Education
It's As Easy as 1, 2, 3
UNLIMITED 1 Year Pass for only $199
About Goodwin Procter LLP
Goodwin is a leading Am Law 50 and Global 50 law firm, with offices across the United States and in Europe and Asia. Excelling at complex transactional work and high-stakes litigation, the firm combines in-depth legal knowledge with practical business experience to help clients maximize opportunities and manage risk. With more than 1,000 lawyers, Goodwin offers innovative counsel and delivers results through a client-centric and collaborative approach. The firm focuses on matters involving financial institutions, intellectual property, private equity, real estate capital markets, securities litigation/white collar defense, and technology/life sciences. Information may be found at www.goodwinlaw.com. Follow us on Twitter @goodwinlaw.
About Benesch Friedlander Coplan & Aronoff LLP
Benesch is an AmLaw 200 business law firm and limited liability partnership with offices in Cleveland, Chicago, Columbus, San Francisco, Wilmington, Hackensack and Shanghai. The firm is known for providing highly sophisticated legal services to national and international clients that include public and private, middle market and emerging companies, as well as private equity funds, entrepreneurs, not-for-profit organizations, trusts and estates.